Molecular Therapeutics Research Program

Mission

The underlying mission of the Molecular Therapeutics (MT) Program is to translate laboratory findings to the clinic so as to improve the lives of patients with cancer by identifying new molecules, targets and strategies for treating cancer. This highly interactive program includes a cross section of laboratory-based scientists and physicians at Karmanos who meet regularly through programmatic activities, and serve as co-investigators on research grants and investigator-initiated clinical trials.

The MT Program’s overriding goal is to integrate basic and translational scientists working broadly in areas of drug development, new or established therapeutic targets or pathways, and cellular and genetic biomarkers of cancer, with physicians conducting interventional treatment trials at the Karmanos Cancer Institute.  

Scientific Themes

  1. Identify and validate novel therapeutics, targets and pathways for selective tumor targeting.  
  2. Identify cellular/molecular determinants and biomarkers of tumor response.  
  3. Validate clinical effectiveness of new agents in interventional treatment trials.

Program Activities

The MT Program leadership actively supports:

  • Basic-clinical collaborations and translational research through the monthly program meetings
  • Molecular Therapeutics Special Seminars
  • Focused retreats
  • Small working groups or topical conferences
  • An annual Molecular Therapeutics Program Retreat
  • Targeted internal grants with emphasis on collaboration and translational science

Program Leaders

  • Asfar S. Azmi, Ph.D.

    Molecular Therapeutics Program Leader
    Associate Professor, Oncology
    Director, Pancreas Cancer Research Initiative
    Barbara Ann Karmanos Cancer Institute
    Wayne State University School of Medicine
    azmia@karmanos.org

  • Ammar Sukari, M.D.

    Molecular Therapeutics Program Co-Leader
    Barbara Ann Karmanos Cancer Institute
    Associate Professor, Department of Oncology
    Wayne State University School of Medicine
    sukaria@karmanos.org

  • Jeffrey Zonder, M.D.

    Molecular Therapeutics Program Co-Leader
    Barbara Ann Karmanos Cancer Institute
    Professor, Departments of Hematology & Oncology
    Wayne State University School of Medicine
    zonderj@karmanos.org

The Latest From Karmanos Cancer Institute

News

Karmanos Cancer Institute Receives 2025 Women’s Choice Awards® for Cancer Care, Mammogram Imaging, Minimally Invasive Surgery and Patient Experience

The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2025 Best Hospitals for Cancer Care, Mammogram Imaging, Minimally Invasi...

Read More

A Melody of Courage: Sierra’s Cancer Journey After Being Diagnosed with Hodgkin Lymphoma

From a young age, music has been a big part of Sierra Watson’s life. In seventh grade, she started playing the bassoon. It became a passion of her...

Read More

IN THE NEWS – NSCLC: Racial and Socioeconomic Disparities in Survival Rates

MedPage Today Dipesh Uprety, M.D., FACP , medical oncologist, member of the  Phase I Clinical Trials  and  Thoracic Oncology  ...

Read More
News

WDET | Cancer Warning Label on Alcohol

Listen Now

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now